INFUSYSTEM HOLDINGS, INC
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $143.4M | $134.9M | $125.8M | $109.9M | $102.4M | $97.4M | $81.1M |
| Cost of Revenue | — | $63.1M | $64.5M | $62.7M | $49.4M | $43.8M | $38.6M | $34.2M |
| Gross Profit | — | $80.3M | $70.4M | $63.1M | $60.6M | $58.5M | $58.8M | $46.9M |
| Gross Margin | — | 56.0% | 52.2% | 50.2% | 55.1% | 57.2% | 60.3% | 57.8% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $57.0M | $51.2M | $45.4M | $44.2M | $40.7M | $35.2M | $29.0M |
| Operating Income | — | $11.9M | $6.9M | $4.1M | $1.7M | $2.8M | $8.8M | $3.5M |
| Operating Margin | — | 8.3% | 5.1% | 3.2% | 1.5% | 2.8% | 9.1% | 4.3% |
| Interest Expense | — | — | — | $2.2M | $1.4M | $1.4M | $1.3M | $1.9M |
| Pretax Income | — | $10.6M | $5.1M | $1.9M | $130.0K | $1.3M | $7.5M | $1.5M |
| Income Tax Expense | — | $4.0M | $2.7M | $979.0K | $112.0K | $-163.0K | $-9.8M | $163.0K |
| Net Income | — | $6.6M | $2.3M | $872.0K | $18.0K | $1.4M | $17.3M | $1.4M |
| Net Margin | — | 4.6% | 1.7% | 0.7% | 0.0% | 1.4% | 17.8% | 1.7% |
| EPS (Basic) | — | $0.32 | $0.11 | $0.04 | $0.00 | $0.07 | $0.86 | $0.07 |
| EPS (Diluted) | — | $0.31 | $0.11 | $0.04 | $0.00 | $0.06 | $0.80 | $0.07 |
| Shares Outstanding (Basic) | 20.2M | 20.7M | 21.3M | 21.0M | 20.6M | 20.5M | 20.1M | 19.7M |
| Shares Outstanding (Diluted) | 20.2M | 21.1M | 21.7M | 21.6M | 21.5M | 22.0M | 21.7M | 20.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |